Muhammad Junaid Dar (M Junaid Dar, Junaid Dar)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Top Venues

Nanomedicine (London, England)

Expert opinion on drug delivery

This page only lists publications with an associated author ORCID identifier.

Publications

Anum Munir Awan, Arshad Farid, Shefaat Ullah Shah, Dildar Khan, Fiza Ur Rehman, Muhammad Junaid Dar, Tayyaba Iftikhar, Shakira Ghazanfar, Charis M Galanakis, Abdulhakeem S Alamri, Syed Mohammed Basheeruddin Asdaq, Kifayat Ullah Shah
Nanocrytals-Mediated Oral Drug Delivery: Enhanced Bioavailability of Amiodarone. Pharmaceutics 14 (6) (2022)
Kashif Iqbal, Sidra Khalid, Craig A McElroy, Muhammad Adnan, Gul Majid Khan, Muhammad Junaid Dar
Triple-combination therapy for cutaneous leishmaniasis using detergent-free, hyaluronate-coated elastic nanovesicles. Nanomedicine (London, England) 17 (20) (2022)
Sibgha Batool, Fatima Zahid, Fakhar Ud Din, Syeda Sohaila Naz, Muhammad Junaid Dar, Muhammad Waseem Khan, Alam Zeb, Gul Majid Khan
Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis: in vitro and in vivo analyses. Drug development and industrial pharmacy 47 (3) (2021)
Nadra Khaleeq, Fakhar Ud Din, Anam Sajjad Khan, Samreen Rabia, Muhammad Junaid Dar, Gul Majid Khan
Development of levosulpiride-loaded solid lipid nanoparticles and their in vitro and in vivo comparison with commercial product. Journal of microencapsulation 37 (2) (2020)
Muhammad Junaid Dar, Craig A McElroy, Muhammad Ijaz Khan, Abhay R Satoskar, Gul Majid Khan
Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis. Expert opinion on drug delivery 17 (1) (2019)
Muhammad Junaid Dar, Fakhar Ud Din, Gul Majid Khan
Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell. Drug delivery 25 (1) (2018)